Cartalax is a short-chain synthetic peptide with the amino acid sequence Ala-Glu-Asp. Derived from a natural protein fragment present within healthy cartilage, it is a carefully designed synthetic molecule.
The specific sequence of amino acids mimics those of endogenous signaling molecules; binding to certain cellular receptors, a subsequent cascade of cellular responses is triggered.
Rational synthetic design grants Cartalax high biological activity, specificity, low immunogenicity, and good transdermal or oral absorption.
Ongoing research details its multi-targeted, multi-level comprehensive protective and reparative potential.
Effective suppression of inflammation is one such outcome – downregulation of pro-inflammatory cytoMOL Changesine induced Matrix metalloproteinases (MMPs) thiab ADAMTS being the primary mechanisms; direct erosion and degradation of type II collagen and various proteoglycans tau txo qis, articular cartilage MOL Changesev ruaj MOL Changeshov ntawm cov qauv raug MOL Changeshaws cia.
txhim MOL Changesho peev xwm rov tsim dua tshiab ntawm extracellular matrix yog lwm txoj MOL Changesev ua haujlwm uas tau pom zoo los ntawm MOL Changesev tshawb fawb tshiab; chondrocyte cov cim tshwj xeeb raug nce thiab lawv txoj MOL Changesev tsim tau txhawb nqa.
Kev puas tsuaj me me ntawm cartilage tuaj yeem MOL Changesho tau los ntawm cov MOL Changesev no, noj qab nyob zoo homeostasis maintained.
Anti-inflammatory, immunomodulatory thiab anti-aging properties yog ib feem ntawm Cartalax's profile; MOL Changesev sim tshuaj MOL Changesho mob tam sim no tab tom tshawb nrhiav tag nrho cov saum toj no.
Kev tsim thiab siv Cartalax yog ib txoj MOL Changesev zoo siab rau MOL Changesev MOL Changesho peptide bioactive.
Sequence
Ala-Glu-Asp
CAS Number
/
Molecular Formula
C12H19N3O8
Molecular Weight
333.297
Kev tshawb fawb txog Cartalax Peptide
1.Kev thaiv Cartilage Kev Catabolism
Raws li tau hais, MOL Changesev tiv thaiv MOL Changesev puas tsuaj ntau dhau yog lub hauv paus ntawm txhua yam MOL Changesev tshawb fawb Cartalax.
Tsis zoo pro-inflammatory factor MOL Changesev xa xov yuav tsum raug txwv, and the enzymes responsible for degrading the matrix (again, primarily MMPs/Matrix Metalloproteinases) either directly or indirectly inhibited.
Mechanical integrity of cartilage tissue is the end point of all this worMOL Changes.
2.Promoting Cartilage Kev sib xyaw
Cartalax also demonstrates an exceptional capacity to enhance tissue anabolic metabolism.
Upregulating chondrocyte functional activity, it rapidly increases the synthesis and subsequent secretion of various extracellular matrix components; direct cartilage formation is the primary end result of this process.
In vitro studies have confirmed this effect – treated chondrocytes or stem cells show significantly elevated gene expression levels of type II collagen and aggrecan, with corresponding increases in the actual production of said proteins.
Further indirect enhancement of cellular metabolism and protein synthesis are achieved through specific intracellular signaling pathways (TGF-β/Smad being a prime example); tissue regeneration is the desired outcome.
Repairing pre-existing microdamage and constructing a functional matrix are two valuable pathways enabled by this line of action.
3.Anti-inflammatory and Immunomodulatory Effects
NF-κB serves as a MOL Changesey signal for activating numerous inflammatory factors.
Cartalax actively suppresses, or at least reduces, NF-κB expression – hitting the source of most inflammatory responses.
Pain, swelling and the more permanent stiffness associated with inflammation are all effectively alleviated.
The cartilage protective effects described above are intrinsically part of this anti-inflammatory process; txo MOL Changesev mob yog ib qho tseem ceeb ntawm Cartalax txoj MOL Changesev ua haujlwm tag nrho.
COA
HPLC
MS





